Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice

Vaccine

Volumn 31, Issue 47, 2013, Pages 5518-5523

  Kueakhai, Pornanan ^a,b   Changklungmoa, Narin ^a   Riengrojpitak, Suda ^a   Chaichanasak, Pannigan ^c   Meemon, Krai ^a   Chaithirayanon, Kulathida ^a   Chantree, Pathanin ^a   Sansri, Veerawat ^d   Itagaki, Tadashi ^e   Sobhon, Prasert ^a  

^a Mahidol University   (Thailand)

^b BURAPHA UNIVERSITY   (Thailand)

^c MAHANAKORN UNIVERSITY OF TECHNOLOGY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e IWATE UNIVERSITY   (Japan)

Author keywords

Fasciola gigantica; Mice; Protection; Saposin like protein 2; Vaccine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FREUND ADJUVANT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; LIVER ENZYME; PARASITE ANTIGEN; RECOMBINANT FASCIOLA GIGANTICA SAPOSIN LIKE PROTEIN 2; RECOMBINANT PROTEIN; SAPOSIN LIKE PROTEIN 2; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ESCHERICHIA COLI; FASCIOLA GIGANTICA; FASCIOLIASIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOBLOTTING; METACERCARIA; MOUSE; NONHUMAN; PARASITE; PARASITE DEVELOPMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

FASCIOLA GIGANTICA; MICE; PROTECTION; SAPOSIN-LIKE PROTEIN 2; VACCINE;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FASCIOLA; FASCIOLIASIS; FREUND'S ADJUVANT; GENE EXPRESSION; HELMINTH PROTEINS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED ICR; RECOMBINANT PROTEINS; SAPOSINS; VACCINATION; VACCINES;

EID: 84886797705     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.027     Document Type: Article

References (37)

1. World health organization (WHO) Report of the WHO informal meeting on use of triclabendazole in fasciolosis control 2006, 1-33. WHO Headquarters, Geneva, Switzerland.
2. Behm C.A., Sangster N.C. Pathology, pathophysiology and clinical aspects. Fasciolosis 1999, 185-217. Cambridge; CABI Publishing, Oxon, UK. J.P. Dalton (Ed.).
3. Kendall S.B., Parfitt J.W. The chemotherapy of fasciolosis. British Veterinary Journal 1962, 118:1-10.
4. Boray J.C. Experimental fasciolosis in Australia. Advances in Parasitology 1969, 7:95-210.
5. Sinclair K.B. Pathogenesis of Fasciola and other-flukes. Helminthological Abstracts 1967, 36:115-134.
6. Boray J.C. Liver fluke disease in sheep and cattle. Primefect 2007, 446:1-10.
7. Okaiyeto S.O., Salami O.S., Dnbirni S.A., Allam L., Onaja I.I. Clinical: gross and histopathological changes associated with chronic fasciolosis infection in a dairy form. Journal of Veterinary Advances 2012, 2(8):444-448.
8. Overend D.J., Bowen F.L. Resistance of Fasciola hepatica to triclabendazole. Australian Veterinary Journal 1995, 72:275-276.
9. Lane G. Anthelmentic resistance. Veterinary Record 1998, 143(8):232.
10. Moll L., Gaasenbeek C.P., Vellema P., Borgsteede F.H. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in the Netherlands. Veterinary Parasitology 2000, 919(1-2):153-158.
11. Brenan G.P., Fairweather I., Trudgett A., Hoey E., McCoy M.C.M., Meaney M., et al. Understanding triclabendazole resistance. Experimental and Molecular Pathology 2007, 82:104-109.
12. Dalton J.P., Mulcahy G. Parasite vaccines - a reality. Veterinary Parasitology 2001, 98:149-167.
13. Maggioli G., Acosta D., Silveira F., Rossi S., Giacaman S., Basika T., et al. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep. Vaccine 2011, 29:9057-9063.
14. Piacenza L., Acosta D., Basmadjian I., Dalton J.P., Carmona C. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fasciolosis in sheep. Infection and Immunity 1999, 67(4):1954-1961.
15. Golden O., Flynn R.J., Reed C., Sekiya M., Donnelly S.M., Stack C., et al. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). Vaccine 2010, 28:5551-5557.
16. Maggioli G., Silveira F., Martin-Alonso J.M., Salinas G., Carmona C., Parra F. A recombinant thioredoxin-glutathione reductase from Fasciola hepatica induces a protective response in rabbits. Experimental Parasitology 2011, 129:323-330.
17. Espino A.M., Hillyer G.V. A novel Fasciola hepatica saposin-like recombinant protein with immunoprophylactic potential. Journal of Parasitology 2004, 90:876-879.
18. Espino A.M., Morales A., Delgado B., Rivera F.M., Figueroa O., Suárez E. Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct. Ethnicity and Disease 2010, 20(S1):17-23.
19. Bruhn H. A short guided tour through functional and structural features of saposin-like proteins. Biochemical Journal 2005, 389:249-257.
20. Espino A.M., Hillyer G.V. Molecular cloning of a member of the Fasciola hepatica saposin-like protein family. Journal of Parasitology 2003, 89:545-552.
21. Grams R., Adisakwattana P., Ritthisunthorn N., Eursitthichai V., Vichasri-Grams S., Viyanant V. The saposin-like proteins 1, 2, and 3 of Fasciola gigantica. Molecular and Biochemical Parasitology 2006, 148:133-143.
22. Kueakhai P., Meemon K., Changklungmoa N., Chaithirayanon K., Riengrojpitak S., Sobhon P. Characterization and localization of saposin-like protein 2 (SAP-2) in Fasciola gigantica. Parasitology Research 2011, 108:1493-1500.
23. Kueakhai P., Changklungmoa N., Chaithirayanon K., Songkoomkrong S., Riengrojpitak S., Sobhon P. Production and characterization of a monoclonal antibody against recombinant saposin-like protein 2 of Fasciola gigantica. Acta Tropica 2013, 125:157-162.
24. Preyavichyapugdee N., Sahaphong S., Riengrojpitak S., Grams R., Viyanant V., Sobhon P. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice. Experimental Parasitology 2008, 119:229-237.
25. McCarthy E., Stack C., Donnelly S.M., Doyle S., Mann V.H., Brindley P.J., et al. Leucine aminopeptidase of the human blood flukes, Schistosoma mansoni and Schistosoma japonicum. International Journal for Parasitology 2004, 34:703-714.
26. Dalton J.P., Heffernan M. Thiol proteases released in vitro by Fasciola hepatica. Molecular and Biochemical Parasitology 1989, 35:161-166.
27. Collins P.R., Stack C.M., O'Nell S.M., Doyle S., Ryan T., Brennan G.P., et al. Cathepsin L1, the major protease involved in liver fluke Fasciola hepatica virulence: propeptidase cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells. Journal of Biological Chemistry 2004, 279:17038-17046.
28. Tort J., Brindley P.J., Knox D., Wolfe K.H., Dalton J.P. Proteinases and associated genes of parasitic helminthes. Advances in Parasitology 1999, 43:161-266.
29. Mulcahy G., O'Connor F., McGonigle S., Dowd A., Clery D.G., Andrews S.J., et al. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine 1998, 26(9/10):932-939.
30. Mulcahy G., O'Connor F., Clery D.G., Hogan S.F., Dowd A.J., Andrews S.J., et al. Immune responses of cattle to experimental anti-Fasciola hepatica vaccine. Research in Veterinary Science 1999, 67(1):27-33.
31. Clery D., Torgerson P., Mulcahy G. Immune responses of chronically infected adult cattle to Fasciola hepatica. Veterinary Parasitology 1996, 63(1/2):71-82.
32. Moreau E., Chauvin A. Immunity against helminthes: infections with the host and the intercurrent infections. Journal of Biomedicine and Biotechnology 2010, 428593.
33. Sandeman R.M., Howell M.J. Response of sheep to challenge infection with Fasciola hepatica. Research in Veterinary Science 1981, 30:294-297.
34. Ford E.J.H. Activity of gamma-glutamyl transpeptidase and other enzymes in the serum of sheep with liver or kidney damage. Journal of Comparative Pathology 1974, 84(2):231-243.
35. Chantree P., Phatsara M., Meemon K., Chaichanasak P., Changklungmoa N., Kueakhai P., et al. Vaccine potential of recombinant cathepsin B against Fasciola gigantica. Experimental Parasitology 2013, 135:102-109.
36. Changklungmoa N., Kueakhai P., Riengrojpitak S., Chaithirayanon K., Chaichanasak P., Preyavichyapugdee N., et al. Immunization with recombinant leucine aminopeptidase showed protection against Fasciola gigantica in mice. Parasitology Research 2013, 112:3653-3659.
37. Sethadavit M., Meemon K., Jardim A., Spithill T.W., Sobhon P. Identification, expression and immunolocalization of cathepsin B3, a stage-specific antigen expressed by juvenile Fasciola gigantica. Acta Tropica 2009, 112:164-173.